Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5187-5194

  Peng, Wen Jia ^a   He, Qian ^a   Yang, Jin Xia ^a   Wang, Bing Xiang ^a   Lu, Man Man ^a   Wang, Song ^a   Wang, Jing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Interleukin; Meta analysis; Polymorphism; Tumor necrosis factor alpha

Indexed keywords

ALANINE; CYCLOOXYGENASE 2; CYSTEINE; GLYCINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; THREONINE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CYCLOOXYGENASE 2 GENE; DNA POLYMORPHISM; GENE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HOMOZYGOSITY; HUMAN; INTERLEUKIN 10 GENE; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; LUNG CANCER; RISK ASSESSMENT; TUMOR NECROSIS FACTOR ALPHA GENE; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; META ANALYSIS; PUBLISHING; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CYTOKINES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS;

EID: 84863768621     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1315-z     Document Type: Article

References (42)

1. Boyle P, Dresler C (2005) Preventing the lung cancer epidemic. Ann Oncol 16(10):1565-1566
2. Farjadfar A, Mojtahedi Z, Ghayumi MA et al (2009) Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study. Acta Oncol 48(7):971-976
3. Witschi H (2001) A short history of lung cancer. Toxicol Sci 64(1):4-6
4. Esposito L, Conti D, Ailavajhala R et al (2010) Lung cancer: are we up to the challenge? Curr Genomics 11(7):513-518
5. Hecht SS (1999) Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91(14):1194-1210
6. Purdue MP, Hoppin JA, Blair A et al (2006) Occupational exposure to organochlorine insecticides and cancer incidence in the agricultural health study. Int J Cancer 120:642-649
7. Sorahan T, Williams SP (2005) Mortality of workers at a nickel carbonyl refinery, 1958-2000. Occup Environ Med 62(2):80-85
8. Biggeri A, Barbone F, Lagazio C et al (1996) Air pollution and lung cancer in Trieste, Italy: spatial analysis of risk as a function of distance from sources. Environ Health Perspect 104(7):750-754
9. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87(6):2095-2147
10. Brichory FM, Misek DE, Yim AM, Krause MC et al (2001) An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA 98(17):9824-9829
11. Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334(26):1717-1725
12. Wilson AG, Symons JA, McDowell TL et al (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94(7): 3195-3199
13. Koki A, Khan NK, Woerner BM et al (2002) Cyclooxygenase-2 in human pathological disease. Adv Exp Med Biol 507:177-184
14. Bi N, Yang M, Zhang L et al (2010) Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer. Clin Cancer Res 16(8): 2383-2390
15. Hida T, Yatabe Y, Achiwa H et al (1998) Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58:3761-3764
16. Beretta L, Cappiello F, Barili M et al (2007) Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis. Tissue Antigens 69(4):305-312
17. Shih CM, Lee YL, Chiou HL et al (2005) The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer 50(3):291-297
18. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629-634
19. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-102
20. Banerjee I (2010) Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis. Eur J Epidemiol 25(7):449-458
21. Beger C, Berlin JA (1988) Publication bias: a problem in interpreting medical data. J R Stat Soc A 151:419-463
22. Liu CJ, Hsia TC, Wang RF et al (2010) Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients. Anticancer Res 30(4):1195-1199
23. Colakogullari M, Ulukaya E, Yilmaztepe Oral A et al (2008) The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGFbeta gene polymorphisms among Turkish lung cancer patients. Cell Biochem Funct 26(3):283-290
24. Seifart C, Plagens A, Dempfle A et al (2005) TNF-alpha, TNFbeta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers 21(3):157-165
25. Huang Y, Bi Y, Luo M et al (2005) TNF-alpha gene polymorphism in patients with lung squamous carcinoma. Natl Med J China 85(15):1064-1065
26. Stankovic MM, Nestorovic AR, Tomovic AM et al (2009) TNFalpha-308 promoter polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Neoplasma 56(4):348-352
27. Shih CM, Lee YL, Chiou HL et al (2006) Association of TNFalpha polymorphism with susceptibility to and severity of nonsmall cell lung cancer. Lung Cancer 52(1):15-20
28. Flego V, Radojcic Badovinac A, Bulat-Kardum L et al (2009) Primary lung cancer and TNF-alpha gene polymorphisms: a casecontrol study in a Croatian population. Med Sci Monit 15(7):CR361-CR365
29. Campa D, Hung RJ, Mates D et al (2005) Lack of association between polymorphisms in inflammatory genes and lung cancer risk. Cancer Epidemiol Biomarkers Prev 14(2):538-539
30. Campa D, Zienolddiny S, Maggini V et al (2004) Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 25(2):229-235
31. Vogel U, Christensen J, Wallin H et al (2008) Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 639(1-2):89-100
32. Lim WY, Chen Y, Mohamed Ali S et al (2011) Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 32(4):522-529
33. Zienolddiny S, Ryberg D, Maggini V et al (2004) Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109(3):353-356
34. Wu KS, Zhou X, Zheng F et al (2010) Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer. Clin Chim Acta 411(19-20): 1441-1446
35. Lee KM, Shen M, Chapman RS et al (2007) Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 28(7):1437-1441
36. Hao M, Wang W, Ye L et al (2009) Association of genetic polymorphism within promoter region of TNF-a, IL-1b and IL-10 with the susceptibility to lung cancer. J Environ Occup Med 26(1):24-27
37. Asada M, Yasuda H, Ebihara S et al (2006) Interleukin-1beta gene polymorphisms associated with risk of lung cancer in Japanese. Lung Cancer 54(2):261-263
38. Park JM, Choi JE, Chae MH (2006) Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study. BMC Cancer 6:70
39. Hu Z, Miao X, Ma H et al (2005) A common polymorphism in the 30UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer 48(1):11-17
40. Sorensen M, Autrup H, Tjonneland A et al (2005) A genetic polymorphism in prostaglandin synthase 2 (8473, T→C) and the risk of lung cancer. Cancer Lett 226(1):49-54
41. de Waal Malefyt R, Abrams J, Benett B, Figdor CG, de Vries J (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monozytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220
42. Kiyohara C, Yoshimasu K (2007) Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a metaanalysis. Int J Med Sci 4(2):59-71